Raremark founder, Julie Walters won the award for “Best Investment in a High Growth Woman Founder” at the UK Business Angels Association (UKBAA) Angel Investment Awards 2016, which took place in London last night. The UKBAA is a cornerstone of the UK’s early-stage growth and investment community, and its annual awards recognize the very best achievements in this field.
Julie founded Raremark in January 2015 with a mission to transform one million lives in rare disease. She previously co-founded two other companies: Tudor Reilly Health, a pioneer in online clinical trial recruitment and retention; and Media Speak, for communications training.
Julie said: “I’m thrilled to achieve this recognition among such a distinguished group of entrepreneurs and hope it inspires more women to set up and run high-growth businesses.”
The Cass Entrepreneurship Fund, which is a member of the UKBAA alongside many other early-stage UK funds, led the recent investment round into Raremark. Helen Reynolds, Investment Director of the Fund, said: “Managing a growth business takes real skill and a careful cultivation of resources to leverage market opportunities. We’re delighted to be part of Raremark’s success in providing capital and broader resources to support ongoing business growth.”
See the full list of UKBAA Awards 2016 winners at http://ukbaa-awards.uk/2016-shortlist/
Raremark’s mission is to transform one million lives in rare disease. Its proprietary platform removes feelings of isolation by opening up a world of trusted and verified information through the indexing of over 2,000 scientific articles and medical guidelines for each disease. Users can comment and share knowledge, connect with specialist centers of research and find out about potential drugs in development. Visit: www.raremark.com